These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38529600)

  • 1. Current Progress on Central Cholinergic Receptors as Therapeutic Targets for Alzheimer's Disease.
    Nagori K; Pradhan M; Sharma M; Ajazuddin ; Badwaik HR; Nakhate KT
    Curr Alzheimer Res; 2024; 21(1):50-68. PubMed ID: 38529600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promising Therapies for Alzheimer's Disease.
    Confaloni A; Tosto G; Tata AM
    Curr Pharm Des; 2016; 22(14):2050-6. PubMed ID: 26876218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease: Targeting the Cholinergic System.
    Ferreira-Vieira TH; Guimaraes IM; Silva FR; Ribeiro FM
    Curr Neuropharmacol; 2016; 14(1):101-15. PubMed ID: 26813123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment.
    Lombardo S; Maskos U
    Neuropharmacology; 2015 Sep; 96(Pt B):255-62. PubMed ID: 25514383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer's Disease.
    Ahmed T; Zahid S; Mahboob A; Farhat SM
    Curr Neuropharmacol; 2017; 15(4):480-494. PubMed ID: 27012953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.
    Auld DS; Kornecook TJ; Bastianetto S; Quirion R
    Prog Neurobiol; 2002 Oct; 68(3):209-45. PubMed ID: 12450488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.
    Hampel H; Mesulam MM; Cuello AC; Farlow MR; Giacobini E; Grossberg GT; Khachaturian AS; Vergallo A; Cavedo E; Snyder PJ; Khachaturian ZS
    Brain; 2018 Jul; 141(7):1917-1933. PubMed ID: 29850777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease and acetylcholine receptors.
    Kihara T; Shimohama S
    Acta Neurobiol Exp (Wars); 2004; 64(1):99-105. PubMed ID: 15190684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.
    Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG
    Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?
    Hernandez CM; Dineley KT
    Curr Drug Targets; 2012 May; 13(5):613-22. PubMed ID: 22300028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review of the Cholinergic System and Therapeutic Approaches to Treat Brain Disorders.
    Bertrand D; Wallace TL
    Curr Top Behav Neurosci; 2020; 45():1-28. PubMed ID: 32451956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.
    Pákáski M; Kálmán J
    Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond Acetylcholinesterase Inhibitors: Novel Cholinergic Treatments for Alzheimer's Disease.
    Kamkwalala AR; Newhouse PA
    Curr Alzheimer Res; 2017; 14(4):377-392. PubMed ID: 27697062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease.
    Kar S; Slowikowski SP; Westaway D; Mount HT
    J Psychiatry Neurosci; 2004 Nov; 29(6):427-41. PubMed ID: 15644984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting brain α7 nicotinic acetylcholine receptors in Alzheimer's disease: rationale and current status.
    Vallés AS; Borroni MV; Barrantes FJ
    CNS Drugs; 2014 Nov; 28(11):975-87. PubMed ID: 25248971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholinesterase inhibition in Alzheimer's Disease.
    Ibach B; Haen E
    Curr Pharm Des; 2004; 10(3):231-51. PubMed ID: 14754384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.
    Tiernan CT; Ginsberg SD; He B; Ward SM; Guillozet-Bongaarts AL; Kanaan NM; Mufson EJ; Counts SE
    Neurobiol Dis; 2018 Sep; 117():125-136. PubMed ID: 29859871
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.